Renaissance Technologies LLC Purchases Shares of 678,808 Danaher Corporation $DHR

Renaissance Technologies LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the first quarter, Holdings Channel.com reports. The institutional investor purchased 678,808 shares of the conglomerate’s stock, valued at approximately $128,702,000.

Several other large investors also recently bought and sold shares of DHR. Pennington Partners & CO. LLC boosted its holdings in Danaher by 37.3% in the 1st quarter. Pennington Partners & CO. LLC now owns 2,191 shares of the conglomerate’s stock valued at $416,000 after purchasing an additional 595 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in Danaher by 0.4% in the first quarter. Public Employees Retirement System of Ohio now owns 257,127 shares of the conglomerate’s stock valued at $48,751,000 after purchasing an additional 1,046 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Danaher by 0.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,639,630 shares of the conglomerate’s stock valued at $690,074,000 after acquiring an additional 11,578 shares in the last quarter. Caxton Associates LLP acquired a new position in shares of Danaher during the 1st quarter worth approximately $1,064,000. Finally, Spear Holdings RSC Ltd acquired a new position in shares of Danaher in the first quarter worth $52,917,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
• Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
• Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
• Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
• Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction

Analyst Ratings Changes

DHR has been the subject of a number of recent research reports. HSBC lowered their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. TD Cowen cut their price target on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Price Performance

Danaher stock opened at $191.87 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.65. The firm has a 50 day moving average price of $185.64 and a 200 day moving average price of $197.04. The company has a market cap of $134.88 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 2.40 and a beta of 0.79.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm posted $0.77 earnings per share. Danaher’s revenue was up 5.5% on a year-over-year basis. Sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 28.42%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.